HL-300 not checked
Hangzhou Highlightll Pharmaceutical Co., Ltd
FollowEvery change as it happens, and a Monday email
Trials
5 active
8 in total · 6 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Group A receives the investigational product at a concentration of 0.25%, BID,4 weeks.”In the company’s words, NCT07629778 on ClinicalTrials.gov
- Tested for
- Atopic Dermatitis
- Main trialPhase 1/2
- “This study is a randomized, double-blind, placebo-controlled, multicenter Phase Ib/II clinical study designed to evaluate the efficacy, safety, and PK characteristics of HL-300 ointment with different concentration regimens for mild-to-moderate AD.”In the company’s words, NCT07629778 on ClinicalTrials.gov
Other drugs for Atopic Dermatitis
Coming up1
- 30 Jun 2027Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials8
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 30 Jun 2027 | HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis | |
| Phase 1Completed | 25 Nov 2024 | HL-300 Ointment in Healthy Volunteers | |
| Phase 3Authorised | not given | A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | |
| Phase 3Authorised | not given | A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure | |
| Phase 3/4Ended | not given | The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation | |
| Phase 2Not authorised | not given | A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE | |
| Phase 2Authorised | not given | Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial | |
| Phase 3Authorised | not given | Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026